Compare ACLS & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACLS | MIR |
|---|---|---|
| Founded | 1995 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Machinery/Components |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.6B |
| IPO Year | 2000 | 2020 |
| Metric | ACLS | MIR |
|---|---|---|
| Price | $122.18 | $14.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $101.50 | $27.25 |
| AVG Volume (30 Days) | 339.2K | ★ 4.0M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 161.11 |
| EPS | ★ 1.05 | 0.02 |
| Revenue | ★ $839,048,000.00 | N/A |
| Revenue This Year | $1.93 | $23.95 |
| Revenue Next Year | $7.91 | $7.32 |
| P/E Ratio | ★ $114.86 | $745.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $73.60 | $14.11 |
| 52 Week High | $193.78 | $30.28 |
| Indicator | ACLS | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 43.21 | 45.47 |
| Support Level | $78.17 | $14.11 |
| Resistance Level | $147.88 | $16.08 |
| Average True Range (ATR) | 5.73 | 0.51 |
| MACD | -0.82 | 0.01 |
| Stochastic Oscillator | 20.39 | 38.64 |
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.